178270 Sigma-AldrichApamin, Bee Venom - CAS 24345-16-2 - Calbiochem
Polypeptide neurotoxin known to pass through the blood-brain barrier.
More>> Polypeptide neurotoxin known to pass through the blood-brain barrier. Less<<Synonyms: CNCKAPETALCARRCQQH-NH₂
Recommended Products
Overview
Replacement Information |
---|
Key Specifications Table
CAS # | Empirical Formula |
---|---|
24345-16-2 | C₇₉H₁₃₁N₃₁O₂₄S₄ |
Products
Catalog Number | Packaging | Qty/Pack | |
---|---|---|---|
178270-500UG | Plastic ampoule | 500 μg |
References | |
---|---|
References | Mourre, C., et al. 1997. Brain Res. 778, 405. Silva, E.G., et al. 1994. Br. J. Pharmacol. 113, 1022. Wang, X., et al. 1994. Brain Res. 662, 83. |
Product Information | |
---|---|
CAS number | 24345-16-2 |
ATP Competitive | N |
Form | White solid with dark tan cast |
Hill Formula | C₇₉H₁₃₁N₃₁O₂₄S₄ |
Chemical formula | C₇₉H₁₃₁N₃₁O₂₄S₄ |
Hygroscopic | Hygroscopic |
Reversible | N |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | AHP-type Ca2+-activated K+ channel |
Purity | ≥98% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | N |
Peptide Sequence | H-Cys¹-Asn-Cys³-Lys-Ala-Pro-Glu-Thr-Ala-Leu-Cys¹¹-Ala-Arg-Arg-Cys¹⁵-Gln-Gln-His-NH₂ (disulfide bonds: 1 → 11; 3 → 15) |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS | |
---|---|
RTECS | CD6899900 |
Safety Information | |
---|---|
R Phrase | R: 20/21/22 Harmful by inhalation, in contact with skin and if swallowed. |
S Phrase | S: 36 Wear suitable protective clothing. |
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Catalog Number | GTIN |
178270-500UG | 04055977223156 |
Documentation
Apamin, Bee Venom - CAS 24345-16-2 - Calbiochem SDS
Title |
---|
Apamin, Bee Venom - CAS 24345-16-2 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
178270 |
References
Reference overview |
---|
Mourre, C., et al. 1997. Brain Res. 778, 405. Silva, E.G., et al. 1994. Br. J. Pharmacol. 113, 1022. Wang, X., et al. 1994. Brain Res. 662, 83. |